Meeting Register Page

Global Pharma strategy, Roche
Global Pharma Strategy
Roche is the largest pharmaceutical company in the world, followed by Pfizer.
Curious about why Roche was first at obtaining FDA authorization for a Covid test? Why was Roche able to ship 400,000 tests on March 13th? Whether long-term focus and decentralization is why Roche performs better than other pharma companies?
Roche’s annual return on investment was 23% last five years. Higher than Amazon (7%), Pfizer (13%), Johnson & Johnson (15%), as well as Microsoft, Intel, Costco, and PepsiCo. The revenue of Roche exceeds $65 Billion, and its market capitalization is $294 Billion.

Mr. Rutschmann, Head of Strategic Finance at Roche, will discuss how pharmaceutical companies make strategic decisions. Mr. Rutschmann is Mr. Benaroya’s guest at the International Business & Competitiveness session.
Participants are encouraged to email questions in advance to gbenaroya@usal.es.

Read more about this session here:
https://wp.nyu.edu/speakers/current/global-pharma-strategy/

--- - ---- -- ----- -------- ----:
http://wp.nyu.edu/speakers/current/

Jan 19, 2021 12:00 PM in Eastern Time (US and Canada)

Meeting logo
Loading
* Required information